# Stage 19 - Value Realization Report

**Decision:** Technical control value demonstrated; operational, clinical and financial value not demonstrated.

## Measured POC evidence

- 55/57 frozen evaluation cases pass internal structural execution; zero fail; two human cases inconclusive.
- 73/73 automated tests pass.
- 20/20 paired shadow runs preserve the same domain outcomes with AI off versus fake assistant.
- 10/10 simulated AI-off canary journeys complete with valid audit.
- Local deterministic p95 is below the pre-registered 250 ms micro-benchmark threshold.
- Backup/restore preserves the state digest and audit chain.

## What the evidence supports

The clean architecture can express source-specific authority, evidence provenance, bitemporal history, fail-closed readiness, authorized identity resolution, safe command retries/reconciliation and Quality-only release in a reproducible synthetic POC.

## What remains unproven

The ten supplied business KPI baselines were provided but not reproducible from supplied formulas. No real before/after population, user study, labor measure, journey outcome, production load, model cost or supplier price exists. Therefore no claim is made for reduced vein-to-vein time, avoided delay, on-time infusion, productivity, adoption, savings, ROI, clinical outcome or compliance.

AI adds no proven value yet: the fake adapter tests controls only. The rational operating decision is AI off until a live-model and human Arm B/C study demonstrates benefit without P0 degradation.
